Important strategies for a plan's medical management team

It wasn't too long ago that the clinical staff and practitioners in the medical management arena of health plans only focused on the quality and continuity of care with their members. These objectives were very important, and should continue to be the focus of any medical management team. However, in more recent times, it has become just as important for the clinical areas of health plans to become aware of the costs of care they incur and to become involved in the control of those costs.

The Patient Protection and Affordable Care Act of 2010 mandates that health insurers report plan costs for the purpose of calculating their medical loss ratio (MLR), which is defined as the percentage of insurance premium dollars spent on reimbursement for clinical services and activities to improve health care quality. Large group insurers must spend at least 85 percent of premium dollars on claims and activities to improve health care quality, while individual and small group insurers must spend at least 80 percent of premium dollars to improve health care quality. If insurers fail to meet these minimum MLRs in a given year, they are required to provide a rebate to their members.

Thus, as a barometer of a health plan's solvency, management of the MLR is an important strategy for the plan's medical management arena. For example, the effective use of health information technology, or medical economics, can be one of the best assets for a health plan in controlling costs and service levels, especially when there may be an increase in plan membership. In addition, investing in quality improvements, such as electronic health records for the plan's provider network, or a web portal for the exchange of health care information can indirectly help to improve the health plan's MLR by reducing administrative costs. Reviewing the utilization data of the health plan's services to determine areas of over or under utilization, and monitoring the process for the authorization of member services are two additional important means for medical management to identify unnecessary costs that may be occurring.

Although there are multiple ways to look for an optimal MLR for health plans through medical management functions, the ultimate goal should be to monitor and take action to improve key indicators affecting MLR, such as the management of complex / high cost members, network contracts with providers and ancillary groups, inpatient performance, and pharmacy utilization, all of which can help to improve a health plan's overall financial performance.

 

Resources

On Friday, September 26 Join John Gorman, GHG's Founder and Executive Chairman together with colleague, John Nimsky, Senior Vice President of Healthcare Innovations, as they discuss the vehicles for achieving what could be characterized as a reengineering of the health care delivery process and its effectiveness. Register today >>

On Tuesday, August 19, GHG's Senior Vice President, Bill MacBain and Senior Vice President of Healthcare Innovations, John Nimsky, explored the drivers and trends in cost and revenue which affect your MLR. Access the webinar recording here >>

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>


Another Flood of Good News for Medicare Advantage

Last week the Centers for Medicare and Medicaid Services (CMS) did its annual data dump for the 2015 Medicare Advantage (MA) and Prescription Drug Plan (PDP) bids.  Even with MA plans sailing into the worst rate environment in over 15 years, the data offered another flood of good news for the industry.

Several takeaways from our first review of the terabytes of CMS data:

  • 2015 will look a lot like 2014, with slightly fewer plan options. The average MA premium will rise $2.94/month, or $1.30/month on an enrollment-weighted basis, and 61% of MA enrollees will see no premium increase.  Having said that, zero-premium options are down 18% in 2015, following a 14% decline this year as previously-free plans institute modest monthly fees to offset payment rate cuts in the Affordable Care Act (ACA).  It speaks to how well the market is working as plans compete intensely for share.
  • The number of MA plan bids were down 4.3%, but most of the reduction was attributable to non-renewing Private Fee-for-Service plans, and good riddance -- PFFS remains the worst policy fart in Medicare. PFFS products are down 31% next year following a 61% year-over-year decline in 2014.  Network-based plans like HMOs and PPOs were only down 0.9%, showing tremendous commitment to this line of business across the country as MA membership surges past one-third of all Medicare enrollment.
  • PDP bids were down around 7%, mostly attributable to consolidation among Pharmacy Benefit Management companies. Humana remains the cheapest PDP in 33 out of 34 regions.  Aetna will get auto-assignment of low-income beneficiaries in 10 new regions, while WellCare lost auto-assigns in 10 regions.
  • CMS implied MA membership in 2015 at 16.9 million, or growth of just 2.7%. That's very conservative -- we expect 5-8% growth in 2015, following 10% growth in 2014.  CMS suggested that MA enrollment is up 42% over 2010 levels -- stunning growth that defies the funeral dirge played for the private Medicare option the year the ACA passed.
  • Most of the major publicly-traded MA sponsors are keeping or expanding their service areas in 2015.  Eminent analyst Josh Raskin of Barclay's points out that publicly-traded companies' enrollment growth in 2014 is up 9% year-to-date, while all others are at 8%.
  • Humana continues to account for 25% of all MA/Special Needs Plan offerings nationally.

"Since the Affordable Care Act was enacted, enrollment in Medicare Advantage plans is now at an all-time high, and premiums have fallen," said CMS Administrator Marilyn Tavenner. "Seniors and people with disabilities are benefiting from a transparent and competitive marketplace for Medicare health and drug plans."

The good news didn't end there.  MA quality continues to improve as the Star Ratings performance-based payment system continues to punch WAY above its weight.  40% of MA contracts were awarded 4+ Stars for 2015, but 60% of enrollees are members of those plans, showing a 30% increase since 2012 and demonstrating the competitive advantage high-performing plans now enjoy. Beneficiaries are now choosing higher-quality plan options in far greater numbers, and ALL of the roughly 200 plans we work with have made Stars their top priority for focus and investment. Stars has proven to be a game-changer in MA and a model all other government-sponsored programs from Medicaid to ObamaCare's marketplaces are beginning to follow.  NCQA's 2015 health plan rankings show California-based Kaiser once again leading the pack among Medicare plans.

To me, the CMS data shows the triumph of government-sponsored, highly-regulated insurance markets.  Medicare Advantage is one of the few examples of government getting it mostly right in partnering with private-sector companies to accomplish a tremendous public good, and continues to be a beacon of hope as ObamaCare enters what promises to be an even tougher second season.

For more updates, follow me on twitter @JohnGorman18

 

Resources

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>

Join John Gorman, GHG's Founder and Executive Chairman together with colleague, John Nimsky, Senior Vice President of Healthcare Innovations, as they discuss the vehicles for achieving what could be characterized as a reengineering of the health care delivery process and its effectiveness. Register today >>


Gearing up for 2016 — Look Ahead, Plan Ahead

As if you are not busy enough, now is the time to start looking towards both 2016 and the future, to ensure you have the correct products in your marketplace as well as determine whether it is time to either increase or decrease the size of your market. Understanding and really knowing your current membership, plus why your members enroll/disenroll, is the first step. Some of the questions that have to be answered are:

  • What does your member look like by product and where do they live?
  • What age did they purchase your product?
  • How long have they been with your organization?
  • When do members tend to disenroll and why?
  • Are there any usage patterns that are helpful in understanding benefit design opportunities?
  • Do you know how they purchased your product (online, by mail, phone or with agent)? Understanding where your dollars were spent to acquire the membership allows you to adjust and adapt during the shortened annual election period (AEP).

Do not forget to understand your service area/marketplace as a whole.

  • When was the last time you did a detailed competitive analysis?
  • Have you included a detailed network analysis?
  • Enrollment trends and product distribution by competitor?
  • Is there a possibility to have a service area expansion?

Even if you are just thinking of entering the marketplace, now is the time for forward thinking initiatives.

If you missed my webinar on September 10, join the Point and you will be able to listen to "Look Ahead — Plan Ahead, Key Insights To Market Share & Growth" webinar.

Resources

Smart benefit design is a dynamic process that begins with an examination of intended markets with consideration given to strengths in member retention and medical management, and is executed with specific enrollment and financial targets in mind. Whether your organization is just entering the government programs space or is already well-established, our team is standing by to assist. Contact us today >>

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>

Join John Gorman, GHG's Founder and Executive Chairman together with colleague, John Nimsky, Senior Vice President of Healthcare Innovations, as they discuss the vehicles for achieving what could be characterized as a reengineering of the health care delivery process and its effectiveness. Register today >>


Bombshells from MedPAC on Medicare Advantage Retention

The Medicare Payment Advisory Commission (MedPAC ), the nonpartisan blue-chip Congressional uber-nerds on our favorite entitlement program, met this week and the staff report presented a couple bombshells on retention rates in Medicare Advantage (MA).

In the aggregate, the commission noted that in 2012 the voluntary disenrollment rate from plans was slightly below 10%. The vast majority of individuals who disenrolled -- 80% -- switched to another MA plan, with the remaining 20% going back to traditional Medicare.  Bombshell #1: we're seeing an overall MA retention rate of roughly 98%, and speaks to the tremendous popularity of the program vs. "old school" coverage.

The commission also noted:

  • When beneficiaries changed plans, a large majority picked another plan with a lower premium.
  • Beneficiaries who elected to switch back to traditional Medicare from MA had higher average cost per beneficiary vs. those who stayed in MA.  Does this indicate that sicker beneficiaries feel they'll get less hassles and/or better care in unmanaged fee-for-service Medicare? I doubt it.  More likely: once back in unmanaged Medicare they go on a wild utilization binge. Why? Because...
  • Older MA enrollees are less likely to disenroll than younger ones. This is puzzling, given the finding above and the direct correlation between income, age and health status in the elderly.  Older beneficiaries are, on average, poorer and sicker than younger ones.

On a plan-specific basis, Star ratings also correlate positively with member retention. Bombshell #2: MA plans with 2 or less Stars experienced a 17% disenrollment rate, while plans with 4 Stars or higher had a disenrollment rate of 4.9%. That's an incredible statistic, showing the rapid effectiveness of Stars impacting the member experience at the plan level in just a couple years.  Stars has truly become a game-changing indicator of quality across health plan functions.

All of this speaks to the fundamental triumph of Medicare Advantage: for those who know, it's the far superior option for senior care.  And once they're in, they don't leave.

Resources

Join GHG for an in-depth discussion on the end-to-end management of data from noting identified gaps in data processing, concerns regarding data completeness and accuracy. Register now >>

To succeed in Medicare Advantage, plans must achieve higher quality and Star Ratings, surmount CMS and medical loss ratio (MLR) requirements, and develop member onboarding and retention capabilities, all while operating in a highly competitive market. Learn how GHG can help ensure your MA plan is positioned to make the most of the program's opportunity. 

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>


CMS's Star Ratings Firing Squad Gets Squirt Guns

Last week, in a surprise move, the Centers for Medicare and Medicaid Services (CMS) reversed its threat to terminate all Medicare Advantage and Part D health plans with 3 or fewer Stars for more than 3 consecutive years.  Roughly a dozen health plans were lined up in front of the firing squad as an example to the industry for months -- and then CMS issued squirt guns to the executioners. 

It's a one-year stay of execution, with the one year of course being an election year.  Importantly, CMS said it will terminate contracts if plans do not achieve at least a 3-star rating by 2016.  Our favorite agency maintains the authority to deny applications submitted by poor performers,  and to deny an application if it has terminated an MA or PDP contract within the past 38 months. There is a 14 month "grace period" for new plans to comply.

CMS Medicare Chief Sean Cavanaugh made the surprise announcement (beginning at 20:30 on the YouTube video) Thursday along with a September 8 policy letter that went to a handful of media outlets, but strangely isn't posted on the CMS website or communicated to Medicare plans via the Health Plan Management System.  The memo noted:

"In delaying the terminations of these low performing contracts, CMS expects all contracts that have for at least three years received...a Rating of less than 3 stars to concentrate on improving the quality of care provided to their enrollees. These contracts must focus on the overall health care needs of their individual enrollees, including improving enrollee experiences and ensuring that their enrollees receive needed clinical care. These efforts should improve CAHPS, HEDIS, HOS, patient safety, and adherence scores. Organizations and sponsors should focus on all areas where the contract has received less than 3 stars. Organizations and sponsors must take into account their enrollee populations and target any interventions to improve quality to the specific needs of their enrollees. In many cases, a one-size-fits-all approach for interventions will not work.

"CMS may be following up with contracts designated as having a low performing icon (LPI) to discuss their performance and will determine whether enforcement or compliance measures other than contract termination pursuant to §§ 422.510(a)(4)(xi) and 423.509(a)(4)(x) should be utilized to ensure that the contract comes into compliance with CMS' requirements."

Barclay's eminent analyst Josh Raskin pointed out that "WellCare is the biggest beneficiary of this change with 9.5% of its total Medicare Advantage members enrolled in plans with consistently (i.e., three consecutive years) less than 3-stars."  Raskin looked at how publicly-traded Medicare Advantage plans' 2.5 and 2.0 star enrollment trended over the past two years.  He concluded over 200,000 Medicare Advantage lives are at risk when the stay of execution is over next year.  "Among the companies with the greatest risk, Centene is most exposed, with roughly 19% of its membership in plans below three stars, followed by Universal American with 16% and WellCare with roughly 12% of its membership in plans below three stars," he said.

On the positive side, Raskin noted Humana continues to makes strides with the company's "at risk" enrollment declining from roughly 550K lives in 2011 to 25K last year, and that Molina has also made progress, improving the rating of its sole 2.5-star plan above the 3.0-star threshold last year.  All of UnitedHealth's sub 3-star plans increased to a 3-star plan last year, leaving the company with very little "high risk" enrollment.

So, we'll have to wait another year for a public hanging in Star Ratings Square.  But all of this serves as further evidence of what a game-changer Star Ratings have become in government programs, from the crappy consumer information tool they were just 4 years ago. 

 

Resources

Join John Gorman, GHG's Executive Chairman together with colleagues, Glenn Ellerbe, Executive Vice President, Dr. Paul Alexander, Senior Clinical Consultant, and Mae Regalado, Senior Director, for an in-depth discussion on the end-to-end management of data from noting identified gaps in data processing, concerns regarding data completeness and accuracy." Register now >>

Now is the time to analyze your HEDIS data for gaps and identify interventions for your health plans, providers and members. On July 17 GHG experts spoke about HEDIS reporting, the new measures and what's next. Access the recording here >>

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>


Data the Silent Killer

As a seasoned veteran in healthcare operations I've seen firsthand the progression of data utilization by health plans. Despite decades of growth we're not there yet.

In the 1950s and 60s data processing began to take hold. Unfiltered data was the norm. Not much was done with it. Data validation was in its infancy. Business decisions were mostly driven by non-analytical factors.

In the 1970s and 80s information management began grouping similar data and identifying patterns. Basic analytics such as the categorization of data facilitated the ability to draw certain assumptions. On occasion those assumptions were valid but, more often than not, not broadly applicable. We realized what making "assumptions" yielded.

Data usage and sophistication improved considerably in the 1990s and early 2000s. The ability to dig much deeper into the groupings of data to find those unique characteristics to either prove or invalidate business assumptions became the mainstay. Better analytical processes improved knowledge and predictability in business decisions. Data management was equated to business intelligence, highlighting the awareness that data functions effectively drive business operations. Improved ability to manage and report data ushered the evolution of Big Data. Analytics and reporting is assumed (there's that word again) to be truthful...the data doesn't lie!

Today, health plan data is heavily relied upon. Data must be valid, accurate, and reproducible; it is the sole factor for health plan payments, performance ratings, patient care plans, and just about every other aspect of health plan operations. Data has become the lifeblood of a managed care organization. But…what if your data is distorted and data leakage is occurring?

What if claims and encounters are improperly adjudicated and reported?
What if membership and provider data is inaccurate?
What if the data used in Disease Management programs relies incorrect metrics to optimize interventions?
What if the data required for risk adjustment submission and payment is inaccurate? How much will it cost your plan?

Poor data management, inaccurate and inadequate analytics can slowly drain a health plan of its revenue and ability to make strategic business decisions. Consider this much like high blood pressure is the silent killer in human beings; data leakage is the silent killer of health plans.

Gorman Health Group has decades of experience assisting health plans with their data management. Please contact us for an End-to-End Data Management Assessment. We will assess the current state of your Data Management against industry best practices and your desired future state, and we'll assist you in getting there. Let us help you identify and control your health plan Silent Killer.

 

Resources

Join us on September 19 for an in-depth discussion on the end-to-end management of data from noting identified gaps in data processing, concerns regarding data completeness and accuracy. Register now >>

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>


Why Medicare ACOs Were Always a Bad Deal, and Why They Need an Exit Strategy

Last week, the tenth of 32 Medicare Pioneer ACOs dropped out of the program.  Others are expressing reservations about entering or continuing given the experience of Pioneers and the hundreds participating in the Medicare Shared Savings Program (MSSP).  To be clear, it's not all bad news...but most ACOs will need an exit strategy, fast.

Medicare ACOs were never a fair deal.  As I pointed out last week, the problem with the Pioneers, and in fact with all Medicare ACOs, is that the rules tilt the playing field toward CMS, often to the detriment of the ACO. Most significantly, the downside risk, as required by CMS, is irrational.  Any ACO incurs substantial downside risk in the form of its investments to participate and its operating costs.

A rational deal would be: the ACO incurs operating costs, and it gets a share of any savings it generates.  The risk is that savings are not enough to cover costs.  Your reward is that you keep any excess over operating costs, although CMS couldn't resist putting a ceiling on that, too.  Adding a financial penalty if costs exceed the benchmark doubles down on the downside, giving the ACO two ways to lose money, and only one way to make money — by generating savings in excess of costs.  Losses incur a penalty, in addition to operating costs.  Small gains still leave a loss if operating costs are not covered -- so only large savings offer a profit.  This is not a fair deal, especially for ACOs in already-efficient markets like Sharp in San Diego.

In the CMS math, the "losses" that incur downside risk, and require refunds to CMS, result from per capita costs for Part A and B services for assigned beneficiaries exceeding a benchmark.  The benchmark is supposed to represent the per capita cost for these bennies if the ACO did nothing.  Costs below the benchmark represent the degree to which the ACO has succeeded in doing something effective.

I can think of only two scenarios in which costs would exceed this benchmark cost of doing nothing.  One is collusion by the ACO providers to increase Medicare billings.  That is illegal, and already carries stiff penalties, and nobody would try it in a public demonstration. That leaves only one other explanation: the benchmark is supposed to represent the per capita costs if the ACO does nothing.  If the ACO does something and still incurs a loss, that means that the benchmark is defective.  CMS does a poor job of incorporating risk adjustment into the benchmark, and, as in the case of Sharp, the benchmark is not necessarily adjusted year to year at a rate that reflects local market changes.  That means the downside risk imposed by CMS is really a penalty for its inability to get the benchmark right.  That is not a fair deal.

In addition to the problems with the downside risk requirement, even if you do generate large savings, your share of those savings will be reduced unless you achieve near perfection on 33 quality metrics selected by CMS.   The ink is barely dry on the first set of metrics, and CMS is already proposing to change half of them.  When one party to a deal keeps shifting the goal posts, it is not a fair deal.

So as we see it, as many as three-quarters of Medicare ACOs need an exit strategy, and fast.  Many Medicare ACOs' 3-year demos will wrap up in 2015-2016, so as early as next year dozens will look at the significant investments in time and treasure and nonexistent ROI and say, "what's next?"  They have three major choices:

  1. Go back to traditional fee-for-service Medicare with a hole in their budget and scars on their asses. Pursue commercial ACO arrangements that are attractive, and effectively flush the investment in Medicare management down the toilet.
  2. Enter, or go deeper into, contracts with one or more Medicare Advantage plans in the market, leveraging infrastructure and experience into a channel where money can be made and quality rewarded.  Most MA plans recognize that a Medicare ACO with a record of savings and quality is primed to be a good risk partner.
  3. Build your own Medicare Advantage plan and move up the food chain.  A successful Medicare ACO has already mastered the hardest parts of eldercare: care management and an engaged network of high-performing providers.  What's missing is insurance functions, which can be built or bought.

Those Medicare ACOs that choose the latter path have good reason to do so: Medicare Advantage remains a sound investment opportunity in most markets for 5 big reasons:

  • Beginning in 2017, the MA benchmark is guaranteed to grow at the same rate as FFS Medicare, whereas the Medicare ACO benchmark resets every 3 years, confiscating most hope of shared savings.
  • Medicare ACOs have to be good diagnostic coders to avoid losing revenue, whereas in MA that's an enormous financial advantage under risk adjustment.
  • ACOs share their savings with CMS; MA plans keep theirs.  Boom.
  • Medicare ACOs with demonstrated quality watch CMS keep less of what they've already earned, while quality gets MA plans a bonus -- and new entrants automatically start with a 3.5 Star Rating and a 3.5% bonus.
  • Medicare ACO beneficiaries are "free range". There is no lock-in and the same level of benefits for any Medicare provider.  The MA benefit design is a lock-in that favors in-network utilization.  Free range is only tastier when referring to carnivorous treats, not capitalist ones.

Those Medicare ACOs that choose the latter option need to move fast.  To evolve into a Medicare Advantage plan, a Medicare ACO needs to have confirmed its market's financial viability, and then build or arrange for:

  • state licensure and financial reserves, and must hold 100% of risk net of reinsurance;
  • a highly developed function to manage Federal and state regulatory requirements;
  • a sophisticated and accountable sales and marketing structure;
  • transaction processing like eligibility, enrollment and claims;
  • a member-centric member service operation.

These capabilities can be homegrown, obtained from the health plan down the street or from third-party vendors like TMG Health, or some combination thereof.  But either path takes time, and sound health plans aren't built during a fire drill.  A Notice of Intent must be submitted to CMS in November and application made in February for the following contract year -- so at this point you're talking 2016 entry at the earliest, 2017 most likely.

If you're a health system watching this all unfold, let me suggest this: instead of investing in a Medicare ACO, take your money to Vegas or to Medicare Advantage -- in either place you know the rules and the odds.

 

Resources

GHG's comprehensive management solutions provide ACOs in transition with the tools, processes, and expert guidance to drive overall performance through new models of finance, leadership, and clinical value. Contact us today to learn more >>

On September 26 join John Gorman, GHG's Founder and Executive Chairman together with colleague, John Nimsky, Senior Vice President of Healthcare Innovations, as they discuss the vehicles for achieving what could be characterized as a reengineering of the health care delivery process and its effectiveness. Register now >>


Groundhog Day: CMS Issues Best Practice Memo Related to Common Audit Findings

Is it Groundhog Day or does this memo say the same thing as last year? Nope you're not imagining things - In CMS' Memo titled "Common Conditions, Improvement Strategies, and Best Practices based on 2013 Program Audit Reviews" that was released on August 27th, CMS outlines again the industry pitfalls and best practices around common areas of noncompliance identified as a result of CMS Program Audits. You may be saying to yourself "some of this looks familiar" well — you're right.

In fact, it appears that CMS is getting weary of repeating themselves year over year and they've included some language with teeth in this most recent memo. CMS makes two key statements in the 2014 memo — the first is that due to the number of repeat findings year over year, it has been determined that Organizations are not using this memo as CMS intended. The second, and more pointed statement is that Conditions noted in one or more memo will be considered "aggravating circumstance" during an audit and this may adversely affect the overall audit score.

So — what does this mean to your Organization? It means that if you haven't yet done so, now is the time to review each best practice memo provided by CMS and ensure that the recommended process is in place. If not, it's time to create and implement a corrective action plan for each best practice mentioned by CMS that would apply to your Organization. Remember, CMS understands that Organizations aren't perfect, but demonstrating that you're able to identify issues and put a plan in place to remediate those issues is always required.

 

Resources

GHG's team of experts can help you minimize your compliance risk and maximize your time and resources. Contact us today to learn how we can help ensure you are audit ready all the time >>

On September 10, join us for an exploration of why assessing your current position and developing new strategies to drive profitable market share growth is crucial for continued success. Register now >>

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>

 


Passing Marketplace Reasonableness — One More Chance

September 4th was final submission day for Marketplace plans but some worried health plans were asking "what ifs" about their last submission for network access. These plans have re-submitted network updates after two CMS rejections that required correction for failing reasonable access. They have three consecutive wrong guesses on whatever standards CMS believes they have not met. They want to know what happens if CMS doesn't approve their network access plan. Of course, they are still asking what standards need to be met.

Rest assured, CMS says they will have another bite to justify reasonable access. However, time periods shrink. The window opens on September 23 when CMS notifies health plans about needed corrections and responses are due on September 25.

CMS is well aware that failure to get a pass has unwanted consequences for everyone. Service areas will need to be reduced with compounding changes to plan packages that necessitate more CMS re-review and approval. So, everyone wants a good justification but CMS is not backing off given the potential for political backlash. Failure is an option. Health plans worried about their last re-submission can't count on CMS reviewer fatigue. Health plans asking these "what if " questions need to prepare a contingency narrative by either finding and fixing any weaknesses or documenting metrics that demonstrate access. Waiting to correct over a two-day window, is not sufficient time to prepare the last chance narrative justification for reasonable access.

 

Resources

Gorman Health Group's network evaluation service deploys an automated software solution that uses metrics based on population, provider ratios and time/distance standard. Learn more >>

Join John Gorman, GHG's Founder and Executive Chairman together with colleague, John Nimsky, Senior Vice President of Healthcare Innovations, as they discuss the vehicles for achieving what could be characterized as a reengineering of the health care delivery process and its effectiveness. Register now >>

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>


ObamaCare Derangement Syndrome Fades, Medicaid Expands.

Last week's approval of Pennsylvania's Medicaid expansion waiver by the Centers for Medicare and Medicaid Services (CMS) may have been good medicine for ObamaCare Derangement Syndrome among Red State governors. Growing numbers are beginning to see the light and resistance to expansion is beginning to crumble like stale crackers.  Expansion momentum is building in Republican-led states after Pennsylvania's change of heart. Indiana, Tennessee, Utah and now Wyoming (!) may be next in line seeking CMS approval for their conservative-oriented expansion proposals. These custom Medicaid expansion proposals include administration by risk-bearing private health plans, increased beneficiary cost-sharing, job search requirements, and mandatory health assessments, among other conservative tenets.

What's finally bringing them to the table after PA's approval?  A flurry of studies this summer, including the White House Council of Economic Advisors, the Urban Institute, and a PwC Institute report, noting that non-expansion states will lose out on over $420B in federal funds between 2014 and 2022, but are still contributing to expansion in other states through Federal taxes, and are doing violence to hospitals, often economic anchors of their communities. Urban's conclusions were particularly clear:

  • The decision of state leaders not to expand Medicaid also means their local hospitals will collectively forgo $167.8 billion in Medicaid reimbursement payments over the same timeframe.
  • Based on analyses of state budgets, for every $1 a state spends expanding Medicaid, $13.41 in federal funding flows into the state.
  • In total, hospitals in states not expanding stand to forgo $167.8 billion in reimbursement funding from 2013 to 2022.

The drumbeat has stripped raw the opposition for what it is: the last vestiges of ObamaCare Derangement Syndrome.  Economic rationality is beginning to take hold.  And that's good for the nation's health.

While the Obama Administration has laudably and consistently shown its willingness to deal with Republican Governors on Medicaid expansion, it definitely isn't writing blank checks.  PA applied for 29 different statutory waivers for its expansion program and was awarded 5AR and IA got tough-love deals from CMS too.  This next cabal of RedGovs will need to show similar willingness to compromise -- imagine that -- to get their Medicaid expansion visions realized.

Resources

Join John Gorman, GHG's Founder and Executive Chairman for an exploration of why assessing your current position and developing new strategies to drive profitable market share growth is crucial for continued success. Register now >>

Save the Date for the Gorman Health Group 2015 Forum. Join us April 7-9, 2015 at the Gaylord National Resort and Convention Center in National Harbor, MD. Learn more about the event >>